This report contains a detailed study of the UK biotechnology industry and its various segments. The UKs biotechnology sector is the largest in Europe and the second largest in the world after the US. The industry reported a revenue growth of 19% during 2001-2003. The market is forecast to reach a value of US$8.5 billion in 2005. The report employs Micheal Porters Five Forces model and the PEST framework for analysis.
The report also profiles the leading firms of the industry - Acambis, Cambridge Antibody Technology and Vernalis - and provides their competitive positioning. It also discusses the strategies adopted by these firms in details. The report also includes a brief financial analysis of the competing firms. The report finally ends with a broad future outlook regarding the industry and its overall performance.
